| Not Yet Recruiting | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safet NCT07519070 | Haisco Pharmaceutical Group Co., Ltd. | Phase 3 |
| Not Yet Recruiting | A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of RC010 Inhalation NCT07528703 | Nanjing Reju Therapeutics Co., Ltd | Phase 1 |
| Not Yet Recruiting | A PhaseⅠ Study of HW252001 in Healthy Subjects NCT07493031 | Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. | Phase 1 |
| Recruiting | A Phase Ia Clinical Trial of HW241045 NCT07448194 | Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. | Phase 1 |
| Recruiting | SB17170 Phase 2 Trial in IPF Patients NCT06747923 | SPARK Biopharma | Phase 2 |
| Active Not Recruiting | Assessment of Self-Care in Patients With Idiopathic Pulmonary Fibrosis (IPF) NCT07139925 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Recruiting | P4O2 ILD Extension NCT06644144 | Amsterdam UMC, location VUmc | — |
| Completed | Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF NCT06331624 | GRI Bio Operations, Inc. | Phase 2 |
| Completed | A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation Phase I Clinical Study to Assess the Sa NCT06310746 | Shanghai Henlius Biotech | Phase 1 |
| Active Not Recruiting | Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-I NCT05983471 | Melius Pharma AB | Phase 2 |
| Recruiting | Phase I Study to Assess Safety, Tolerability, PK and PD of AGMB-447 in Healthy Participants and Participants W NCT06181370 | Agomab Spain S.L. | Phase 1 |
| Completed | Application of Personalized Palliative Care in Patients With Newly Diagnosed Idiopathic Pulmonary Fibrosis NCT06714188 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Active Not Recruiting | Diarrheal Adverse Events in Caucasian Patients With Idiopathic Pulmonary Fibrosis Undergoing Treatment With Ni NCT06714812 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Completed | A Multiple Ascending Doses (MAD) Study of PMG1015 in Idiopathic Pulmonary Fibrosis Subjects NCT05895565 | Pulmongene Ltd. | Phase 1 |
| Completed | A Study to Evaluate the Safety, Tolerability, PK and PD of HNC1058 NCT05803850 | Guangzhou Henovcom Bioscience Co. Ltd. | Phase 1 |
| Withdrawn | A Phase 2 Study to Evaluate Safety and Efficacy of AMB-05X in Subjects With Idiopathic Pulmonary Fibrosis NCT05349760 | AmMax Bio, Inc. | Phase 2 |
| Completed | Prognostic Score Comparison in IPF and HP NCT07169253 | Saglik Bilimleri Universitesi | — |
| Active Not Recruiting | Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary NCT05570058 | Redx Pharma Ltd | Phase 2 |
| Completed | Effects of Home-based Inspiratory Muscle Training in Patients With IPF NCT05353556 | Dokuz Eylul University | N/A |
| Recruiting | Turkish Validity and Reliability of SGRQ-I NCT05147597 | Saglik Bilimleri Universitesi | — |
| Recruiting | Sleep Hygiene, Sarcopenia, and Cognitive Function in Respiratory Disease NCT05193136 | National Hospital Organization Minami Kyoto Hospital | — |
| Recruiting | Telerehabilitation in Patients With Idiopathic Pulmonary Fibrosis NCT05190211 | Istanbul Medipol University Hospital | N/A |
| Completed | ILAs in CT Lung Cancer Screening Population NCT04503044 | Lahey Clinic | — |
| Active Not Recruiting | Advancing Prevention of Pulmonary Fibrosis NCT04564183 | University of Colorado, Denver | — |
| Terminated | A Study of Patients With Chronic Disease NCT04263727 | Target PharmaSolutions, Inc. | — |
| Terminated | A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF NCT03864328 | Respivant Sciences GmbH | Phase 2 |
| Unknown | Inhaled NO in IPF and COPD During 6 Minute Walk Test NCT03873298 | Rabin Medical Center | Phase 2 |
| Recruiting | The Role of Laryngopharyngeal Reflux in IPF NCT03418350 | National Jewish Health | — |
| Completed | Idiopathic Pulmonary Fibrosis Job Exposures Study NCT03211507 | Imperial College London | — |
| Unknown | The Coagulation Cascade in Idiopathic Pulmonary Fibrosis NCT02885961 | University College, London | N/A |
| Completed | Safety, Tolerability, and Efficacy of MN-001 (Tipelukast) in Patients With Idiopathic Pulmonary Fibrosis NCT02503657 | MediciNova | Phase 2 |
| Unknown | Nasal, Tracheal and Bronchial Mucosal Lining Fluid(MLF) Sampling From Patients With Respiratory Diseases NCT02807025 | Imperial College Healthcare NHS Trust | — |
| Completed | Functional MR Lung Imaging Using Hyperpolarised 129Xe NCT02976935 | University of Nottingham | — |
| Completed | Prospective Evaluation of Biomarker Profiles in Idiopathic Pulmonary Fibrosis NCT02151435 | University of Michigan | — |
| Completed | The Effectiveness of Pulmonary Rehabilitation on Saturation in Patients With Idiopathic Pulmonary Fibrosis NCT07031362 | Izmir Katip Celebi University | N/A |
| Completed | Combined PEX, Rituximab and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations NCT01266317 | Michael Donahoe | Phase 1 / Phase 2 |